Empowering Tomorrow Through the Strength of Awareness DENVER, CO, UNITED STATES, March 9, 2026 /EINPresswire.com/ -- On ...

The Prostate Cancer Foundation (PCF) today announced the recipients of its 2025 Challenge Awards, providing over $12 million in funding for 12 multi-institutional, cross-disciplinary research teams ...

The Damon Runyon Cancer Research Foundation has announced its newest class of Damon Runyon Fellows, 14 exceptional postdoctoral scientists conducting basic and translational cancer research in the ...

Inspired by Hippocrates himself, a revolutionary in the practice of medicine, The Hippocratic Cancer Research Foundation seeks to eliminate cancer and save lives by funding the discovery, development ...

They plan to reach a combined 3,339 — around Galbraith Mountain and Lake Padden — by Sept. 1, the same day Fox ended his run ...

NEW YORK, Dec. 2, 2025 /PRNewswire/ -- The Lung Cancer Research Foundation® (LCRF) awarded its annual 2025 Scientific Grant Program awards, funding another $1.65 million in new research. This year's ...

NFL's largest annual fundraiser announces milestone ahead of its signature run, walk and cycling event, DCC XVI, scheduled for Feb. 28, 2026 The Miami Dolphins announced today that the Dolphins […] ...

Over the past two decades, the DeGregorio Family Foundation has awarded just under $10 million in 38 competitive research grants to leading scientists at premier institutions including Dana-Farber ...

Officials at Pediatric Cancer Research Foundation say “a revolutionary moment” is occurring, with regards to the newest research to treat children’s cancers. “It’s fantastic research—cutting edge ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

Many cancer treatments were developed for adult physiology, not pediatric biology, resulting in disproportionate long-term ...

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...